29 May, 2017
On Tuesday, September 20 the stock rating was maintained by Citigroup with "Buy". The company has a 50 day moving average of $54.26 and a 200-day moving average of $55.26. Celestica had 14 analyst reports since October 21, 2015 according to SRatingsIntel. The firm has "Neutral" rating by Bank of America given on Thursday, November 17. As per Monday, August 24, the company rating was upgraded by Piper Jaffray. The firm has "Buy" rating by B. Riley & Co given on Friday, October 23. The firm has "Hold" rating given on Monday, August 10 by Stifel Nicolaus. The stock has "Equal Weight" rating by Barclays Capital on Tuesday, December 1. The stock of Alphabet Inc (NASDAQ:GOOG) has "Overweight" rating given on Wednesday, August 12 by Morgan Stanley. UBS has "Buy" rating and $75 target. Then see the current price relative to the highest moving average and you will have a "back of the envelope" technical indicator in your back pocket for any stock at any time. FLR's SI was 4.91M shares in May as released by FINRA. Gamble Jones Inv Counsel holds 0.78% or 120,420 shares. Moreover, Mariner Wealth Advsr Limited Liability Corp has 0.18% invested in Bristol-Myers Squibb Co (NYSE:BMY) for 65,373 shares. Company insiders own 0.24% of the company's stock.
All things being equal, stocks with higher earnings-per-share growth rates are generally more desirable than those with slower earnings-per-share growth rates. Investors typically pay increased attention to stocks that are nearing either the 52-week high or 52-week low mark. It has underperformed by 39.89% the S&P500.
Bristol-Myers Squibb Company Profile Bristol-Myers Squibb Company is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products. The company has market cap of $6.24 billion. The Company's pharmaceutical products include chemically synthesized drugs, or small molecules, and products produced from biological processes called biologics. It has a 14.82 P/E ratio.
Investors sentiment decreased to 0.97 in 2016 Q4. Its down 0.16, from 1.13 in 2016Q3. Fruth Invest reported 20,717 shares. Dynamic Advisors Solutions Ltd Liability Corp invested 0.57% in Bristol-Myers Squibb Co (NYSE:BMY). Green Square Capital LLC increased its position in shares of Bristol-Myers Squibb by 0.3% in the third quarter.
City Holding Co. raised its position in shares of Bristol-Myers Squibb Co (NYSE:BMY) by 15.6% during the first quarter, Holdings Channel reports. 7,324 are held by Highlander Capital Management Llc. West Coast Financial LLC increased its position in shares of Bristol-Myers Squibb by 0.3% in the third quarter. Supplemental Annuity Collective Of Nj reported 25,211 shares.
Raging Capital Management Llc holds 0.87% of its portfolio in Glu Mobile Inc. for 6.04 million shares. After $0.84 actual earnings per share reported by Bristol-Myers Squibb Co for the previous quarter, Wall Street now forecasts -13.10% negative EPS growth. LEUNG SANDRA also sold $5.27 million worth of Bristol-Myers Squibb Co (NYSE:BMY) on Friday, March 3. Wealthcare Management has 0% invested in Bristol-Myers Squibb Co (NYSE:BMY) for 175 shares. Quadrant Capital Group LLC's holdings in Bristol-Myers Squibb were worth $607,000 at the end of the most recent reporting period.
Bristol-Myers Squibb Co (NYSE:BMY) opened at 53.97 on Friday. Barclays Capital has "Equal-Weight" rating and $65 target. Robert W. Baird initiated the stock with "Outperform" rating in Wednesday, April 26 report. Mairs And Pwr holds 340,822 shares. The stock has earnings growth of 9.10% yoy. Hilliard Lyons initiated Bristol-Myers Squibb Co (NYSE:BMY) on Monday, May 23 with "Neutral" rating. The firm earned "Buy" rating on Friday, April 29 by UBS. The rating was maintained by Jefferies on Tuesday, June 14 with "Hold". The firm earned "Buy" rating on Friday, January 22 by Berenberg.
Since February 27, 2017, it had 1 buy, and 6 insider sales for $9.91 million activity. Also, SVP Joseph C. Caldarella sold 8,096 shares of the firm's stock in a transaction that occurred on Wednesday, March 15th. 15,000 shares were sold by Schmukler Louis S, worth $851,220.
In other news, Director Theodore R. Samuels II bought 12,000 shares of the business's stock in a transaction on Monday, February 27th. Deutsche Bank AG restated a "hold" rating and set a $42.00 target price on shares of Bristol-Myers Squibb in a research report on Thursday, February 16th. It dropped, as 86 investors sold BMY shares while 529 reduced holdings. Northern Trust accumulated 22.01 million shares or 0.39% of the stock. Aperio Limited Co invested in 762,662 shares. Marshall Wace Ltd Liability Partnership reported 513,182 shares stake. 157,496 are owned by Citigroup. Dalton Greiner Hartman Maher Communications has 5,830 shares. Cranbrook Wealth Mngmt Ltd has 0.01% invested in Symantec Corporation (NASDAQ:SYMC) for 672 shares. State Street Corp now owns 67,670,322 shares of the biopharmaceutical company's stock valued at $3,954,652,000 after buying an additional 2,470,257 shares during the last quarter. About 7.20M shares traded or 0.84% up from the average. The share price is trading in a range of $53.90 - 54.82. Cwm Ltd Company accumulated 58 shares.
Columbus Hill Capital Management Lp decreased Cheniere Energy Partners Lp (NYSEMKT:CQP) stake by 36,060 shares to 307,353 valued at $8.86M in 2016Q4. The stock decreased 1.14% or $0.34 on May 26, reaching $29.61.
Davis R M Inc decreased Mcdonalds Corp (NYSE:MCD) stake by 4,530 shares to 21,461 valued at $2.61 million in 2016Q4. Celestica Inc (NYSE:CLS) has risen 35.94% since May 29, 2016 and is uptrending.
